discharges damage brain areas implicated in emotional regulation and can subsequently lead to long-lasting psychiatric deficits. The psychiatric effects of anti-epileptic medication are significant and can worsen pre-existing psychiatric disorder directly. An indirect mechanism is through the reduction of drug levels of antidepressants/antipsychotics through liver enzyme induction. Moreover there are nutritional deficiencies that can arise with anti-epileptics, eg. folate deficiency with valproate.
Amongst the psychiatric illnesses encountered, depression and anxiety disorders are by far the commonest. Depression affects up to 3 0 % , 6 while anxiety disorders affect roughly 2 5 % of individuals with epilepsy. Psychoses (2%-7%) and personality disorders (1%-2%) are less common but also encountered. 7 A large population based cohort study published recently observed that people with epilepsy have a 2.5 fold increase in risk of developing schizophrenia or schizophrenia-like psychoses -particularly in the absence of a family history of psychosis. 8 This implies that epilepsy is indeed a risk factor for the future development of schizophrenia. Historically, it has been reported that, compared with schizophrenia, the psychoses of epilepsy are associated with better preservation of affect and personality, an increased incidence of visual hallucinations, and purely delusional states and response to treatment with anti-epileptic medication. 9 Realistically, even the most astute of clinicians would have difficulty differentiating the two disorders. However, ascribing the right diagnosis to individuals with the psychoses associated with epilepsy as opposed to schizophrenia has its merits; including the prevention of potential stigma of a psychiatric label and providing more appropriate treatment.
Amongst the ICD-10 classified personality disorders, avoidant and dependent sub-types have been found to predominate among individuals with epilepsy. This possibly relates to the environment of uncertainty regarding seizure experiences and also the ensuing overprotection such individuals may experience from their families. 10 An inter-ictal behaviour syndrome/personality disorder has been described in Temporal Lobe Epilepsy (TLE) whose features include preoccupation with philosophical and religious concerns, anger, excessive emotionality, viscosity, circumstantiality, altered sexuality and hypergraphia." It has been assigned an eponym, the Gastaut-Geschwind syndrome. However a recent review on the issue of an 'epileptic personality' suggests that personality traits rather than a personality disorder per se seems more likely and these tend to resemble the cluster C categorisation of disorders in DSM-IV.' 2 The review concludes by stating that these personality changes are not specific to TLE but also seen in other neurological and nonneurological conditions.
or non-epileptic attack disorder (NEAD) is harder to quantify and rates between 10-50% have been observed, dependent on the treatment setting. 13 NEAD is considered a dissociative disorder in the European setting (ICD-10); however it is a somatoform disorder in the USA (DSM-IV). Despite the international classification differences, these individuals possess common traits: they tend to have higher levels of psychopathology, a history of sexual abuse, are female and up to 3 0 % do possess an underlying seizure disorder.
14 Moreover NEAD tends to manifest before the age of 40 years and is commoner in individuals who have observed a friend or family member with an epileptic illness.
Temporal lobe epilepsy (TLE)
TLE is a sub-type of epilepsy renowned for higher rates of psychiatric illness and rates between 5 0 % -7 0 % are not uncommon.' 516 It is postulated that these higher rates arise due to deficits in the temporal lobe structures that comprise the limbic system and impact on emotional processing and regulation." ,9 Depression affects a significant proportion of individuals with TLE, up to 3 0 % . 7 Anxiety disorders are a close second with rates up to 25%. 7 Psychosis is another entity that is more common in TLE with the association between the temporal lobe and psychosis only being made in the last century. The prevalence of psychoses in TLE is estimated to be between 5 % -1 0 % which is ten times higher than that seen in the general population and in certain settings this figure is more substantial. 24 Psychoses generally tend to manifest approximately 11-15 years after an epileptic disorder is diagnosed 25 with the post-ictal psychoses being by far the most common.
26
The psychoses associated with TLE are generally regarded not to improve with epilepsy surgery and thus such candidates are generally excluded from surgical intervention. However patients with co-morbid schizophrenia need not necessarily be deprived of surgical treatment as they benefit from such therapy. 27 Past researchers have been interested in the neuropathology of psychosis associated with TLE as a 'mock-up' of schizophrenia. 28 However in the surgically resected tissue of such subjects, hamartomas, gangliogliomas and dysembryoblastic neuroepithelial tumours were found in excess, 2930 and
we now see that this neuropathology is quite distinct from that of schizophrenia. 31 It is worth noting that, while epilepsy surgery is a treatment for epilepsy, it is a recognised risk factor for the development of psychosis de novo. In a recent TLE case series, 11 developed psychosis post-operatively among a prospective cohort of 320 individuals within the first post-operative year.
32

Psychiatric disorder and epilepsy treatment
The mainstay of treatment of epilepsy involves medication.
These medications all have the potential to precipitate psychi- 
Treatment of psychiatric disorder in epilepsy
Antidepressants
The antidepressants that are considered safe to use in epilepsy are the selective serotonin re-uptake inhibitors (SSRI's) and the serotonin-noradrenaline re-uptake inhibitors (SNRI's). 33 They have a much lower seizure induction potential relative to the other antidepressants and appear to be well 
Antipsychotics
The safest agents for the treatment of psychosis associated with epilepsy appear to be the atypical agents such as olanzapine, risperidone and quetiapine. 33 They lack significant seizure-threshold lowering potential and have a favourable side-effect profile. Typical antipsychotics such as haloperidol may also be used. Clozapine and chlorpromazine have consistently been shown to have a high propensity to induce seizures and as such their prescription should be precluded.
Conclusion
Epilepsy is associated with significant psychiatric comorbidity and psychiatrists need to possess a good understanding of the particular presentations, treatment and drug interactions relevant to this association. Epilepsy requires a holistic approach in order to promote both good neurological and psychiatric outcomes. 
